Vincente Soriano - Infectious Diseases

Author Information

Vincent Soriano is a distinguished researcher affiliated with the Infectious Diseases Unit at IdiPAZ-La Paz University Hospital and the Autonomous University in Madrid, Spain. His expertise in infectious diseases is well-recognized, and he has made significant contributions to understanding and treating various viral infections, including hepatitis and HIV.

Research Contributions

Vincent Soriano has an extensive research portfolio focused on infectious diseases, particularly hepatitis and HIV. Notable among his contributions is his work on hepatitis C treatment outcomes in individuals co-infected with HIV, as well as studies on occult hepatitis B virus infection. His research extends to clinical presentations of HTLV-1 infection in Spain and the impact of hepatitis delta virus in patients with resolved hepatitis B. Soriano's work has been critical in advancing therapeutic strategies and understanding the biological and clinical implications of viral infections.

Aliases

Throughout his career, Vincent Soriano has published under various names including V. And Soriano, V. Soriano, V Soriano, and Vincente Soriano.

Publication and Citation Metrics

Metric	Value
Total Papers	715
Total Citations	25,631
H-Index	81

Publications:

Hepatitis C Treatment Outcomes in Persons With HIV and Decompensated Cirrhosis Using a Collaborative Multidisciplinary HIV-Centered Approach

DOI: 10.1177/23259582211024771

Year: 2021

Update of the statements on biology and clinical impact of occult hepatitis b virus infection.

DOI: 10.1016/j.jhep.2019.03.034

Year: 2019

Clinical Presentation of Individuals With Human T-Cell Leukemia Virus Type-1 Infection in Spain

DOI: 10.1093/ofid/ofz036

Year: 2019

Short article: Hepatitis delta in patients with resolved hepatitis B virus infection

DOI: 10.1097/MEG.0000000000001187

Year: 2018

Using Clinical Research Networks to Assess Severity of an Emerging Influenza Pandemic

DOI: 10.1093/cid/ciy088

Year: 2018

Increased Indoleamine-2,3-Dioxygenase Activity Is Associated With Poor Clinical Outcome in Adults Hospitalized With Influenza in the INSIGHT FLU003Plus Study

DOI: 10.1093/ofid/ofx228

Year: 2018

Hepatitis Delta Enters a New Therapeutic Era.

DOI: 10.1093/infdis/jix658

Year: 2018

Treatment of hepatitis C with new fixed dose combinations

DOI: 10.1080/14656566.2017.1346609

Year: 2017

Hepatitis delta and HIV infection.

DOI: 10.1097/QAD.0000000000001424

Year: 2017

HTLV infection in HCV-antibody positive patients in Spain.

DOI: 10.1089/AID.2016.0323

Year: 2017

What are Some Examples of Structural Proteins in Infectious Diseases?

How is Malaria Diagnosed and Treated?

What is Real-Time PCR?

What is Mycobacterium Tuberculosis?

Can Symptomatic Relief Replace Primary Treatment?

What is the Treatment for Dengue Hemorrhagic Fever?

What Are Vector-Borne Diseases and How Are They Affected?

What are Receptors?

Is Fatigue a Long-term Issue in Infectious Diseases?

How Can We Address Vaccine Hesitancy?

Partnered Content Networks

Relevant Topics